Crystal structure of Trastuzumab Fab fragment bearing p-azido-L-phenylalanine
Domain Annotation: ECOD Classification ECOD Database Homepage
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
|---|---|---|---|---|---|---|---|---|
| C | Ku_N | e5xhfC1 | A: beta barrels | X: Protein kinase/SAICAR synthase/ATP-grasp | H: Protein kinase/SAICAR synthase/ATP-grasp | T: Undecaprenyl diphosphate synthase | F: Ku_N | ECOD (v294.2) |
| A | ATP-synt_VA_C | e5xhfA1 | A: beta barrels | X: FAD-linked reductases, C-terminal domain-like | H: FAD-linked reductases-C | T: FAD-linked reductases-C | F: ATP-synt_VA_C | ECOD (v294.2) |
| D | ATP-synt_VA_C | e5xhfD1 | A: beta barrels | X: FAD-linked reductases, C-terminal domain-like | H: FAD-linked reductases-C | T: FAD-linked reductases-C | F: ATP-synt_VA_C | ECOD (v294.2) |
| B | Ku_N | e5xhfB1 | A: beta barrels | X: Protein kinase/SAICAR synthase/ATP-grasp | H: Protein kinase/SAICAR synthase/ATP-grasp | T: Undecaprenyl diphosphate synthase | F: Ku_N | ECOD (v294.2) |
Domain Annotation: CATH CATH Database Homepage
| Chain | Domain | Class | Architecture | Topology | Homology | Provenance Source (Version) |
|---|---|---|---|---|---|---|
| C | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| A | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| D | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| B | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
SAbDab Antibody Annotation SAbDab Database Homepage
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|---|---|---|---|---|
| Light Chain | IGKV1 | Kappa | - | SAbDab (2026-05-08) | |
| Heavy Chain | IGHV3 | - | - | SAbDab (2026-05-08) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
| Chain | Name | Target | Provenance Source |
|---|---|---|---|
| Coprelotamab | ERBB2/CD340/HER2, CD3E, TNFRSF9/CD137/4-1BB, SIRPA | Therapeutic SAbDab (2026-05-08) | |
| Coprelotamab | ERBB2/CD340/HER2, TNFRSF9/CD137/4-1BB, SIRPA, CD3E | Therapeutic SAbDab (2026-05-08) |














